Pancreatic cancer research
Around 8,100 people are diagnosed with pancreatic cancer every year in the UK, and the disease is difficult to treat.
Thanks to research, funded by Cancer Research UK and others, some improvements have been made. But we still need to do much more to improve survival from pancreatic cancer.
As part of our five-year strategy we are investing more in research into pancreatic cancer, aiming to save more lives in the future.
Below are some highlights of our pancreatic cancer research. Visit MyProjects to donate directly to our research into the disease.
On this page
Biomarkers
Dr John Timms
Department of Gynaecological Oncology
University College London, London
Searching for better tests for pancreatic cancer
Pancreatic cancer is often diagnosed at an advanced stage, making it very difficult to treat. Dr John Timms heads the Cancer Proteomics group at University College London. His team is looking for biomarkers that could lead to better tests for the disease, and help doctors to detect it earlier.
Dr David Tuveson
Tumour Modelling & Experimental Medicine
Cancer Research UK Cambridge Research Institute, Cambridge
New ways to treat pancreatic cancer
Dr David Tuveson is a leading expert investigating the biology and treatment of pancreatic cancer. He is and his team at Cancer Research UK’s Cambridge Research Institute are using the latest genetic techniques to find new ways to treat the disease. Pancreatic cancer has been recognised by Cancer Research UK as an area that urgently needs more research, and Dr Tuveson’s work will help to meet our goal of improving survival.
Cancer spread (metastasis)
Prof Jeff Evans
Translational Cancer Therapeutics
Beatson Institute for Cancer Research, Glasgow
Stopping pancreatic cancer from spreading
Professor Jeff Evans is based at Cancer Research UK's Beatson Institute in Glasgow, where he is Professor of Translational Cancer Research. He is investigating drugs that could stop pancreatic cancer from spreading, a major problem in this disease.
Drug discovery & development
Prof Duncan Jodrell
Cancer Research UK Cambridge Research Institute
University of Cambridge, Cambridge
Improving cancer treatments
Professor Duncan Jodrell is Professor of Cancer Therapeutics at the University of Cambridge. Professor Jodrell and his team are turning lab into improved treatments for a range of different cancers, including pancreatic cancer.
Professor Michael Shipman
Department of Chemistry
University of Warwick, Coventry
New drugs to treat pancreatic cancer
Professor Michael Shipman is developing a new type of drug to treat pancreatic cancer. He is Professor of Synthetic Chemistry at the University of Warwick.
Dr David Tuveson
Tumour Modelling & Experimental Medicine
Cancer Research UK Cambridge Research Institute, Cambridge
New ways to treat pancreatic cancer
Dr David Tuveson is a leading expert investigating the biology and treatment of pancreatic cancer. He is and his team at Cancer Research UK’s Cambridge Research Institute are using the latest genetic techniques to find new ways to treat the disease. Pancreatic cancer has been recognised by Cancer Research UK as an area that urgently needs more research, and Dr Tuveson’s work will help to meet our goal of improving survival.
Gene therapy
Prof Nick Lemoine
Centre for Molecular Oncology and Imaging
Barts and the London School of Medicine and Dentistry, London
Developing new ways to diagnose and treat cancer
Professor Nick Lemoine is the Director of the Institute of Cancer at Barts and the London School of Medicine and Dentistry. He oversees a multi-million pound programme of research looking at new ways to diagnose and treat many types of cancer. Professor Lemoine is an international expert in pancreatic cancer and much of his work focuses on this disease.
Immunotherapy
Dr Thorsten Hagemann
Centre for Cancer and Inflammation
Barts and The London School of Medicine and Dentistry, London
Reducing inflammation to treat pancreatic cancer
Dr Thorsten Hagemann is a Clinical Lecturer at the Centre for Cancer and Inflammation at Barts and The London School of Medicine and Dentistry. He is investigating how cancer cells can cause inflammation, which protects them from being destroyed by the body's immune system. In particular, his research focuses on pancreatic cancer.
Surgery
Prof John Neoptolemos
Division of Surgery and Oncology
University of Liverpool, Liverpool
Better treatments for pancreatic cancer
Professor John Neoptolemos is Head of the Division of Surgery and Oncology at the University of Liverpool. He combines his clinical work with lab-based research and also runs the Clinical Trials Unit at the Royal Liverpool University Hospital. Professor Neoptolemos is an international expert in the treatment of pancreatic cancer and is researching how survival can be improved for people with this disease.
Vaccine treatment
Prof Nick Lemoine
Centre for Molecular Oncology and Imaging
Barts and the London School of Medicine and Dentistry, London
Developing new ways to diagnose and treat cancer
Professor Nick Lemoine is the Director of the Institute of Cancer at Barts and the London School of Medicine and Dentistry. He oversees a multi-million pound programme of research looking at new ways to diagnose and treat many types of cancer. Professor Lemoine is an international expert in pancreatic cancer and much of his work focuses on this disease.
Prof John Neoptolemos
Division of Surgery and Oncology
University of Liverpool, Liverpool
Better treatments for pancreatic cancer
Professor John Neoptolemos is Head of the Division of Surgery and Oncology at the University of Liverpool. He combines his clinical work with lab-based research and also runs the Clinical Trials Unit at the Royal Liverpool University Hospital. Professor Neoptolemos is an international expert in the treatment of pancreatic cancer and is researching how survival can be improved for people with this disease.
- Share this: Tweet
-
-
- Print this page
-
Email this page
Increase text
Decrease text
Print this page
